Disease Info Card

Smooth Muscle Tumor

Information about Smooth Muscle Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Smooth Muscle Tumor

Most recent studies have shown that Smooth Muscle Tumor shares some biological mechanisms with acquired-immunodeficiency-syndrome, benign-neoplasm, carcinoma, fibroid-tumor, gastrointestinal-neoplasms, gastrointestinal-stromal-tumors, hemorrhage, leiomyoma-epithelioid, leiomyomatosis, leiomyosarcoma, malignant-neoplasms, malignant-paraganglionic-neoplasm, myomatous-neoplasm, neoplasm-metastasis, neoplasms, sarcoma, soft-tissue-neoplasms, stomach-neoplasms, uterine-fibroids, uterine-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Smooth Muscle Tumor, and have been seen in publications frequently: Aging, Angiogenesis, Cell Adhesion, Cell Cycle, Cell Differentiation, Cell Growth, Cell Proliferation, Dedifferentiation, Dna Repair, Enucleation, Localization, Mitosis, Oncogenesis, Parturition, Pathogenesis, Regulation Of Growth, S Phase, Secretion, Smooth Muscle Cell Differentiation

Quite a number of genes have been found to play important roles in Smooth Muscle Tumor, such as CD34, CDKN2A, DES, ESR1, GNAI1, HMGA2, IGF2, KIT, MME, PCNA, PGR, S100A1, S100B, TP53, TP63, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.